Because of its extreme reactivity with oxygen and water, this element occurs naturally only in compounds with other elements, such as in the minerals strontianite and celestite. It is kept under a liquid hydrocarbon such as mineral oil or kerosene to prevent oxidation; freshly exposed strontium metal rapidly turns a yellowish color with the formation of the oxide. Finely powdered strontium metal is pyrophoric meaning it will ignite spontaneously in air at room temperature. Volatile strontium salts impart a bright red color to flames, and these salts are used in pyrotechnics and in the production of flares. Natural strontium is a mixture of four stable isotopes.
The first large scale application of strontium was in the production of sugar from sugar beet. Although a crystallisation process using strontium hydroxide was patented by Augustin-Pierre Dubrunfaut in 1849 the large scale introduction came with the improvement of the process in the early 1870s. The German sugar industry used the process well into the 19th century. Prior to World War I the beet sugar industry used 100,000 to 150,000 tons of strontium hydroxide for this process per year. The strontium hydroxide was recycled in the process, but the demand to substitute losses during production was high enough to create a significant demand initiating mining of strontianite in the Münsterland. The mining of strontianite in Germany ended when mining of the celestite deposits in Gloucestershire started. These mines supplied most of the world strontium supply from 1884 to 1941
Strontium commonly occurs in nature, the 15th most abundant element on earth, averaging 0.034% of all igneous rock and is found chiefly as the form of the sulfate mineral celestite (SrSO4) and the carbonate strontianite (SrCO3). Of the two, celestite occurs much more frequently in sedimentary deposits of sufficient size to make development of mining facilities attractive. Strontianite would be the more useful of the two common minerals because strontium is used most often in the carbonate form, but few deposits have been discovered that are suitable for development. The metal can be prepared by electrolysis of melted strontium chloride mixed with potassium chloride:
:Sr2+ + 2 → Sr :2 Cl− → Cl2 (g) + 2
Alternatively it is made by reducing strontium oxide with aluminium in a vacuum at a temperature at which strontium distills off. Three allotropes of the metal exist, with transition points at 235 and 540 °C.
== Isotopes == Strontium has four stable, naturally occurring isotopes: 84Sr (0.56%), 86Sr (9.86%), 87Sr (7.0%) and 88Sr (82.58%). Only 87Sr is radiogenic; it is produced by decay from the radioactive alkali metal 87Rb, which has a half-life of 4.88 × 1010 years. Thus, there are two sources of 87Sr in any material: that formed in stars along with 84Sr, 86Sr and 88Sr, as well as that formed by radioactive decay of 87Rb. The ratio 87Sr/86Sr is the parameter typically reported in geologic investigations; ratios in minerals and rocks have values ranging from about 0.7 to greater than 4.0. Because strontium has an atomic radius similar to that of calcium, it readily substitutes for Ca in minerals.
Sixteen unstable isotopes are known to exist. Of greatest importance are 90Sr with a half-life of 28.78 years and 89Sr with a half-life of 50.5 days. 90Sr is a by-product of nuclear fission found in nuclear fallout and presents a health problem since it substitutes for calcium in bone, preventing expulsion from the body. This isotope is one of the best long-lived high-energy beta emitters known, and is used in SNAP (Systems for Nuclear Auxiliary Power) devices. These devices hold promise for use in spacecraft, remote weather stations, navigational buoys, etc., where a lightweight, long-lived, nuclear-electric power source is required. The 1986 Chernobyl nuclear accident contaminated a vast area with 90Sr. 90Sr confined inside a concave silver plaque is also used for the medical treatment of a resected pterygium.
89Sr is a short-lived artificial radioisotope that is used in the treatment of bone cancer. In circumstances where cancer patients have widespread and painful bony metastases (secondaries), the administration of 89Sr results in the delivery of radioactive emissions (beta particles in this case) directly to the area of bony problem (where calcium turnover is greatest). The 89Sr is manufactured as the chloride salt (which is soluble), and when dissolved in normal saline can be injected intravenously. Typically, cancer patients will be treated with a dose of 150 MBq. Patients must take precautions following this because their urine becomes contaminated with radioactivity, so they must sit to urinate and double-flush the toilet. The beta particles travel about 3.5 mm in bone (energy 0.583 MeV) and 6.5 mm in tissue, so there is no requirement to isolate patients having been treated, except to say they should not have any one (especially young children) sitting in their laps for 10–40 days. The variation in time results from the variable clearing time for 89Sr, which depends on renal function and the number of bony metastases. With a lot of bony metastases, the entire 89Sr dose can be taken up into bone and so the radioactivity is retained to decay over a 50.5-day half-life. It takes about 10 half-lives or about 500 days for 99.9% of the radioactive strontium to decay. However, where there are few bony metastases, the large proportion of 89Sr not taken up by the bone will be filtered by the kidney, so that the effective half-life (a combination of the physical and biological half-life) will be much shorter.
Strontium is used in scientific studies of neurotransmitter release in neurons. Like calcium, strontium facilitates synaptic vesicle fusion with the synaptic membrane. But, unlike calcium, strontium causes asynchronous vesicle fusion. Therefore, replacing calcium in the culture medium with strontium allows scientists to measure the effects of a single-vesicle fusion event, e.g., the size of the postsynaptic response elicited by the neurotransmitter content of a single vesicle.
In general, strontium salts strontium carbonate are used in the manufacture of fireworks. This is due to the fact that they impart a deep red colour to the firework.
The primary use for strontium compounds is in glass for colour television cathode ray tubes to prevent X-ray emission. All parts of the CRT tube have to absorb X-rays. In the neck and the funnel of the tube, lead glass is used for this purpose, but this type of glass shows a browning effect due to the interaction of the X-rays with the glass. Therefore, the front panel has to use a different glass mixture, in which strontium and barium are the X-ray-absorbing materials. The average values for the glass mixture determined for a recycling study in 2005 is 8.5% strontium oxide and 10% barium oxide.
Other applications are as follows: Ferrite magnets and refining zinc. Strontium titanate has an extremely high refractive index and an optical dispersion greater than that of diamond, making it useful in a variety of optics applications. This quality has also led to its being cut into gemstones, in particular as a diamond simulant. However, it is very soft and easily scratches so it is rarely used.
90Sr has been used as a power source for radioisotope thermoelectric generators (RTGs). 90Sr produces about 0.93 watts of heat per gram (it is lower for the form of 90Sr used in RTGs, which is strontium fluoride). However, 90Sr has a lifetime approximately 3 times shorter and has a lower density than 238Pu, another RTG fuel. The main advantage of 90Sr is that it is cheaper than 238Pu and is found in nuclear waste. Soviet Union deployed nearly 1000 of these RTGs on the northern coast as power source for lighthouses and meteorology stations.
90Sr is also used in cancer therapy. Its beta emission and long half-life is ideal for superficial radiotherapy.
Because strontium is so similar to calcium, it is incorporated in the bone. All four stable isotopes are incorporated, in roughly similar proportions, as they are found in nature (please see below). However, the actual distribution of the isotopes tends to vary greatly from one geographical location to another. Thus, analyzing the bone of an individual can help determine the region it came from. This approach helps to identify the ancient migration patterns as well as the origin of commingled human remains in battlefield burial sites. Strontium, thus, helps forensic scientists too.
87Sr/86Sr ratios are commonly used to determine the likely provenance areas of sediment in natural systems, especially in marine and fluvial environments. Dasch (1969) showed that surface sediments of Atlantic displayed 87Sr/86Sr ratios that could be regarded as bulk averages of the 87Sr/86Sr ratios of geological terranes from adjacent landmasses. A good example of a fluvial-marine system to which Sr isotope provenance studies have been successfully employed is the River Nile-Mediterranean system, Due to the differing ages of the rocks that constitute the majority of the Blue and White Nile, catchment areas of the changing provenance of sediment reaching the River Nile delta and East Mediterranean Sea can be discerned through Sr isotopic studies. Such changes are climatically controlled in the Late Quaternary.
More recently, 87Sr/86Sr ratios have also been used to determine the source of ancient archaeological materials such as timbers and corn in Chaco Canyon, New Mexico. 87Sr/86Sr ratios in teeth may also be used to track animal migrations or in criminal forensics.
A recent in-vitro study conducted the NY College of Dental Sciences using strontium on osteoblasts showed marked improvement on bone-building osteoblasts.
The drug strontium ranelate, made by combining strontium with ranelic acid, was found to aid bone growth, increase bone density, and lessen vertebral, peripheral, and hip fractures. Women receiving the drug showed a 12.7% increase in bone density. Women receiving a placebo had a 1.6% decrease. Half the increase in bone density (measured by X-ray densitometry) is attributed to the higher atomic weight of Sr compared with calcium, whereas the other half a true increase in bone mass. Strontium ranelate is registered as a prescription drug in Europe and many countries worldwide. It must be prescribed by a doctor, must be delivered by a pharmacist, and requires strict medical supervision. , it is not available in Canada or the United States.
There is a long history of medical research regarding strontium's benefits, beginning in the 1950s. Studies indicate a lack of undesirable side-effects. Several other salts of strontium such as strontium citrate and strontium carbonate are available in the United States under the Dietary Supplements Health and Education Act of 1994, providing close to the recommended strontium content, about 680 milligrams per day, of strontium ranelate. Their long-term safety and efficacy have not been evaluated on humans in large-scale medical trials.
Category:Chemical elements Category:Alkaline earth metals Category:Lochaber Category:Strontium Category:Reducing agents
af:Strontium ar:سترونشيوم an:Estroncio az:Stronsium bn:স্ট্রনশিয়াম be:Стронцый bs:Stroncijum bg:Стронций ca:Estronci cv:Стронци ceb:Estronsyo cs:Stroncium co:Stronziu cy:Strontiwm da:Strontium de:Strontium et:Strontsium el:Στρόντιο es:Estroncio eo:Stroncio eu:Estrontzio fa:استرانسیم hif:Strontium fr:Strontium fur:Stronzi ga:Strointiam gv:Stroinçhum gl:Estroncio hak:Sṳ̂ xal:Стронциум ko:스트론튬 hy:Ստրոնցիում hi:स्ट्रोन्सियम hr:Stroncij io:Stroncio id:Stronsium is:Strontín it:Stronzio he:סטרונציום jv:Strontium kn:ಸ್ಟ್ರಾನ್ಶಿಯಮ್ sw:Stronti kv:Стронций ht:Estwontyòm ku:Stronsiyûm mrj:Стронций la:Strontium lv:Stroncijs lb:Strontium lt:Stroncis lij:Stronsio jbo:jinmrstronti hu:Stroncium ml:സ്ട്രോൺഷിയം mr:स्ट्राँशियम ms:Strontium my:စထရွန်တီယမ် nl:Strontium ja:ストロンチウム no:Strontium nn:Strontium oc:Estronci uz:Stronsiy pnb:سٹرونٹیم nds:Strontium pl:Stront pt:Estrôncio ro:Stronțiu qu:Istronsyu ru:Стронций sah:Стронсиум stq:Strontium scn:Stronziu simple:Strontium sk:Stroncium sl:Stroncij sr:Стронцијум sh:Stroncijum fi:Strontium sv:Strontium tl:Istrontiyo ta:இசுட்ரோன்சியம் te:స్ట్రాన్షియం th:สตรอนเชียม tr:Stronsiyum uk:Стронцій ug:سترونتسىي vi:Stronti war:Estronsyo yo:Strontium zh-yue:鍶 zh:锶This text is licensed under the Creative Commons CC-BY-SA License. This text was originally published on Wikipedia and was developed by the Wikipedia community.
The World News (WN) Network, has created this privacy statement in order to demonstrate our firm commitment to user privacy. The following discloses our information gathering and dissemination practices for wn.com, as well as e-mail newsletters.
We do not collect personally identifiable information about you, except when you provide it to us. For example, if you submit an inquiry to us or sign up for our newsletter, you may be asked to provide certain information such as your contact details (name, e-mail address, mailing address, etc.).
When you submit your personally identifiable information through wn.com, you are giving your consent to the collection, use and disclosure of your personal information as set forth in this Privacy Policy. If you would prefer that we not collect any personally identifiable information from you, please do not provide us with any such information. We will not sell or rent your personally identifiable information to third parties without your consent, except as otherwise disclosed in this Privacy Policy.
Except as otherwise disclosed in this Privacy Policy, we will use the information you provide us only for the purpose of responding to your inquiry or in connection with the service for which you provided such information. We may forward your contact information and inquiry to our affiliates and other divisions of our company that we feel can best address your inquiry or provide you with the requested service. We may also use the information you provide in aggregate form for internal business purposes, such as generating statistics and developing marketing plans. We may share or transfer such non-personally identifiable information with or to our affiliates, licensees, agents and partners.
We may retain other companies and individuals to perform functions on our behalf. Such third parties may be provided with access to personally identifiable information needed to perform their functions, but may not use such information for any other purpose.
In addition, we may disclose any information, including personally identifiable information, we deem necessary, in our sole discretion, to comply with any applicable law, regulation, legal proceeding or governmental request.
We do not want you to receive unwanted e-mail from us. We try to make it easy to opt-out of any service you have asked to receive. If you sign-up to our e-mail newsletters we do not sell, exchange or give your e-mail address to a third party.
E-mail addresses are collected via the wn.com web site. Users have to physically opt-in to receive the wn.com newsletter and a verification e-mail is sent. wn.com is clearly and conspicuously named at the point of
collection.If you no longer wish to receive our newsletter and promotional communications, you may opt-out of receiving them by following the instructions included in each newsletter or communication or by e-mailing us at michaelw(at)wn.com
The security of your personal information is important to us. We follow generally accepted industry standards to protect the personal information submitted to us, both during registration and once we receive it. No method of transmission over the Internet, or method of electronic storage, is 100 percent secure, however. Therefore, though we strive to use commercially acceptable means to protect your personal information, we cannot guarantee its absolute security.
If we decide to change our e-mail practices, we will post those changes to this privacy statement, the homepage, and other places we think appropriate so that you are aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it.
If we make material changes to our e-mail practices, we will notify you here, by e-mail, and by means of a notice on our home page.
The advertising banners and other forms of advertising appearing on this Web site are sometimes delivered to you, on our behalf, by a third party. In the course of serving advertisements to this site, the third party may place or recognize a unique cookie on your browser. For more information on cookies, you can visit www.cookiecentral.com.
As we continue to develop our business, we might sell certain aspects of our entities or assets. In such transactions, user information, including personally identifiable information, generally is one of the transferred business assets, and by submitting your personal information on Wn.com you agree that your data may be transferred to such parties in these circumstances.